292 related articles for article (PubMed ID: 29481859)
1. Effect of vinylpyrrolidone polymers on the solubility and supersaturation of drugs; a study using the Cheqsol method.
Fornells E; Fuguet E; Mañé M; Ruiz R; Box K; Bosch E; Ràfols C
Eur J Pharm Sci; 2018 May; 117():227-235. PubMed ID: 29481859
[TBL] [Abstract][Full Text] [Related]
2. Micro-scale solubility assessments and prediction models for active pharmaceutical ingredients in polymeric matrices.
Bochmann ES; Neumann D; Gryczke A; Wagner KG
Eur J Pharm Biopharm; 2019 Aug; 141():111-120. PubMed ID: 31100430
[TBL] [Abstract][Full Text] [Related]
3. Supersaturation of zafirlukast in fasted and fed state intestinal media with and without precipitation inhibitors.
Madsen CM; Boyd B; Rades T; Müllertz A
Eur J Pharm Sci; 2016 Aug; 91():31-9. PubMed ID: 27260089
[TBL] [Abstract][Full Text] [Related]
4. Comparison of induction methods for supersaturation: Amorphous dissolution versus solvent shift.
Plum J; Bavnhøj CG; Eliasen JN; Rades T; Müllertz A
Eur J Pharm Biopharm; 2020 Jul; 152():35-43. PubMed ID: 32376371
[TBL] [Abstract][Full Text] [Related]
5. The twofold advantage of the amorphous form as an oral drug delivery practice for lipophilic compounds: increased apparent solubility and drug flux through the intestinal membrane.
Dahan A; Beig A; Ioffe-Dahan V; Agbaria R; Miller JM
AAPS J; 2013 Apr; 15(2):347-53. PubMed ID: 23242514
[TBL] [Abstract][Full Text] [Related]
6. Influence of excipients on solubility and dissolution of pharmaceuticals.
Paus R; Prudic A; Ji Y
Int J Pharm; 2015 May; 485(1-2):277-87. PubMed ID: 25749073
[TBL] [Abstract][Full Text] [Related]
7. Enhanced delivery of fixed-dose combination of synergistic antichagasic agents posaconazole-benznidazole based on amorphous solid dispersions.
Figueirêdo CBM; Nadvorny D; Vieira ACQM; Schver GCRM; Soares Sobrinho JL; Rolim Neto PJ; Lee PI; Soares MFR
Eur J Pharm Sci; 2018 Jul; 119():208-218. PubMed ID: 29679707
[TBL] [Abstract][Full Text] [Related]
8. Preparation and characterization of dipyridamole solid dispersions for stabilization of supersaturation: effect of precipitation inhibitors type and molecular weight.
Vora C; Patadia R; Mittal K; Mashru R
Pharm Dev Technol; 2016 Nov; 21(7):847-855. PubMed ID: 26333427
[TBL] [Abstract][Full Text] [Related]
9. Formulation strategy and evaluation of nanocrystal piroxicam orally disintegrating tablets manufacturing by freeze-drying.
Lai F; Pini E; Corrias F; Perricci J; Manconi M; Fadda AM; Sinico C
Int J Pharm; 2014 Jun; 467(1-2):27-33. PubMed ID: 24680963
[TBL] [Abstract][Full Text] [Related]
10. Effects of tablet formulation and subsequent film coating on the supersaturated dissolution behavior of amorphous solid dispersions.
Sakai T; Hirai D; Kimura SI; Iwao Y; Itai S
Int J Pharm; 2018 Apr; 540(1-2):171-177. PubMed ID: 29447848
[TBL] [Abstract][Full Text] [Related]
11. Thermodynamics of Highly Supersaturated Aqueous Solutions of Poorly Water-Soluble Drugs-Impact of a Second Drug on the Solution Phase Behavior and Implications for Combination Products.
Trasi NS; Taylor LS
J Pharm Sci; 2015 Aug; 104(8):2583-93. PubMed ID: 26059413
[TBL] [Abstract][Full Text] [Related]
12. Determination of excipient based solubility increases using the CheqSol method.
Etherson K; Halbert G; Elliott M
Int J Pharm; 2014 Apr; 465(1-2):202-9. PubMed ID: 24513529
[TBL] [Abstract][Full Text] [Related]
13. Drug-carrier binding and enzymatic carrier digestion in amorphous solid dispersions containing proteins as carrier.
Pas T; Bergonzi A; Lescrinier E; Vergauwen B; Van den Mooter G
Int J Pharm; 2019 May; 563():358-372. PubMed ID: 30935916
[TBL] [Abstract][Full Text] [Related]
14. An Insight into Different Stabilization Mechanisms of Phenytoin Derivatives Supersaturation by HPMC and PVP.
Otsuka N; Ueda K; Ohyagi N; Shimizu K; Katakawa K; Kumamoto T; Higashi K; Yamamoto K; Moribe K
J Pharm Sci; 2015 Aug; 104(8):2574-82. PubMed ID: 26059285
[TBL] [Abstract][Full Text] [Related]
15. Supersaturation in human gastric fluids.
Bevernage J; Hens B; Brouwers J; Tack J; Annaert P; Augustijns P
Eur J Pharm Biopharm; 2012 May; 81(1):184-9. PubMed ID: 22342777
[TBL] [Abstract][Full Text] [Related]
16. Polymer incorporation method affects the physical stability of amorphous indomethacin in aqueous suspension.
Surwase SA; Itkonen L; Aaltonen J; Saville D; Rades T; Peltonen L; Strachan CJ
Eur J Pharm Biopharm; 2015 Oct; 96():32-43. PubMed ID: 26092472
[TBL] [Abstract][Full Text] [Related]
17. Dissolution and Solubility Enhancement of the Highly Lipophilic Drug Phenytoin via Interaction with Poly(N-isopropylacrylamide-co-vinylpyrrolidone) Excipients.
Widanapathirana L; Tale S; Reineke TM
Mol Pharm; 2015 Jul; 12(7):2537-43. PubMed ID: 26046484
[TBL] [Abstract][Full Text] [Related]
18. Concomitant intake of alcohol may increase the absorption of poorly soluble drugs.
Fagerberg JH; Sjögren E; Bergström CAS
Eur J Pharm Sci; 2015 Jan; 67():12-20. PubMed ID: 25444841
[TBL] [Abstract][Full Text] [Related]
19. Physicochemical properties of tadalafil solid dispersions - Impact of polymer on the apparent solubility and dissolution rate of tadalafil.
Wlodarski K; Sawicki W; Haber K; Knapik J; Wojnarowska Z; Paluch M; Lepek P; Hawelek L; Tajber L
Eur J Pharm Biopharm; 2015 Aug; 94():106-15. PubMed ID: 25998701
[TBL] [Abstract][Full Text] [Related]
20. Role of Molecular Interactions for Synergistic Precipitation Inhibition of Poorly Soluble Drug in Supersaturated Drug-Polymer-Polymer Ternary Solution.
Prasad D; Chauhan H; Atef E
Mol Pharm; 2016 Mar; 13(3):756-65. PubMed ID: 26866895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
